Core Insights - Lianlong (300596) reported a revenue of 2.995 billion yuan for the first half of 2025, representing a year-on-year growth of 6.21% [1] - The net profit attributable to shareholders reached 241 million yuan, up 9.60% year-on-year, with a basic earnings per share of 1.05 yuan, also reflecting a 9.61% increase [1] - The company has maintained a compound annual growth rate of 24.59% in revenue over the past fourteen years, demonstrating strong operational resilience despite international market challenges [1] Business Performance - The high polymer material anti-aging business generated 2.358 billion yuan in revenue, a 3.06% increase year-on-year, with a shipment volume of 65,500 tons, up 4.30% [2] - The lubricant additive business saw significant growth, achieving 618 million yuan in revenue, an 18.49% increase year-on-year, with a shipment volume of 34,200 tons, up 18.27% [2] - The life sciences business has transitioned to a market development phase, with key products achieving stable production and sales, and three products entering mass production [3] Strategic Developments - The company is expanding its global footprint, having established a wholly-owned subsidiary in Singapore and a subsidiary in Malaysia, with plans to invest up to 300 million USD in an overseas R&D and production base [3] - A new management team, primarily composed of individuals born in the 1980s, has taken over daily operations and innovation efforts, marking a significant generational transition for the company [4]